Director, Oncology Business Assessments
Pfizer Statistics Program
Summary
Business Assessment (BA) is a highly collaborative and dynamic team responsible for generating the investment cases for all pipeline and business development decisions. BA sits within Pfizer's Global Commercial Analytics (GCA) organization. The Director partners with commercial leadership, asset leads, Therapeutic Area Leadership Teams, and Worldwide Business Development to champion internal pipeline and external opportunities aligned with strategy and investment criteria.
Job description
Role Summary
Business Assessment (BA) is a highly collaborative and dynamic team responsible for generating the investment cases for all pipeline and business development decisions. BA sits within Pfizer's Global Commercial Analytics (GCA) organization. The Director partners with commercial leadership, asset leads, Therapeutic Area Leadership Teams, and Worldwide Business Development to champion internal pipeline and external opportunities aligned with strategy and investment criteria.
This role independently leads several concurrent commercial assessments — internal POC study-start and Phase 3 business cases, external BD cases, and early pipeline forecasts — ensuring thorough, consistent analysis to inform critical investment decisions and structure appropriate deal terms. The Director also provides strategic input on trade-off decisions between investment options and leads the presentation of analysis and recommendations to oncology leadership.
Role Responsibilities
- Build and own assessments of pipeline and BD opportunities — including epidemiology-based patient flow, treatment rates, uptake and persistency curves, gross-to-net
- Gather input from key internal expert stakeholders on the potential clinical development plan or clinical profile and commercial evaluation
- Develop analytically supported recommendations to facilitate investment trade-off decisions across Business Unit opportunities, as well as BD opportunities compared with internal pipeline investment
- Determine the appropriate level of rigor and external insights/research required depending on the scenario, timeline and decision to be made
- Conduct qualitative and quantitative market research with external physicians and key opinion leaders both directly and through management of consulting resources
- Support development of colleagues, and influence at therapeutic area or product committee level
- Take and defend an independent position before oncology leadership, including recommending against an opportunity on limited information
- Own Oncology's inputs to Operating Plan and Long-Range Forecast cycles, including integration of pipeline and BD forecasts
- Work flexibly and comfortably across multiple therapeutic/tumor areas
- Set the team's standard for AI-enabled assessment: evidence synthesis, competitive landscaping, model QC, and executive materials, with every assumption traceable to its source
- Occasionally support additional BA and GCA projects or enterprise level initiatives and evaluations using analyst reports and other secondary data
Qualifications
- BA/BS required; MBA or life sciences advanced degree preferred
- 8+ years in the biopharmaceutical industry, life sciences consulting, financial services, or another analytical profession (7+ years with an advanced degree)
- Working knowledge of healthcare and pharmaceutical trends, competitor strategy, the drug development process, and healthcare-market dynamics in the US and major ex-US markets
- Demonstrated ownership of patient-based revenue forecasting and business-case work from initial build to executive-ready recommendation
- Able to work with complex information — epidemiology literature, analyst reports, secondary/claims data, primary research — and distill it into an analytic framework
- Track record delivering objective investment recommendations that earn senior-leadership endorsement; strong presentation skills at the executive level
- Experience coaching analytical talent, and setting methodological standards for a team
- Comfortable engaging executive commercial and research leaders at all levels
- Effective in a matrixed organization, leading cross-functional teams with indirect authority
- Business development experience across opportunity identification, commercial assessment, and high-level deal structuring
- Prior experience in biopharma forecasting, life sciences consulting, or financial services
- Oncology forecasting experience preferred; M&A or platform-evaluation experience; demonstrated use of AI/LLM tooling in analytical workflows
Requirements
- BA/BS required
- MBA or life sciences advanced degree preferred
- 8+ years in biopharmaceutical industry, life sciences consulting, financial services, or another analytical profession (7+ years with an advanced degree)
- Working knowledge of healthcare and pharmaceutical trends, competitor strategy, drug development process, and healthcare-market dynamics in US and major ex-US markets
- Demonstrated ownership of patient-based revenue forecasting and business-case work
- Ability to work with complex information (epidemiology literature, analyst reports, secondary/claims data, primary research) and distill into analytic framework
- Track record delivering objective investment recommendations to senior leadership
- Strong presentation skills at executive level
- Experience coaching analytical talent and setting methodological standards
- Comfortable engaging executive commercial and research leaders
- Effective in matrixed organization leading cross-functional teams with indirect authority
- Business development experience across opportunity identification, commercial assessment, and high-level deal structuring
- Prior experience in biopharma forecasting, life sciences consulting, or financial services
- Oncology forecasting experience preferred
- M&A or platform-evaluation experience preferred
- Demonstrated use of AI/LLM tooling in analytical workflows preferred
- Candidates must be authorized to be employed in the U.S. by any employer
- U.S. work visa sponsorship is not available for this role now or in the future
Benefits
- 401(k) Matching
- Retirement Savings Contribution
- Paid Vacation
- Paid Holidays
- Paid Personal Days
- Paid Caregiver Leave
- Paid Parental Leave
- Paid Medical Leave
- Medical, Dental & Vision
- Prescription Drug Coverage
- Long-Term Incentive Program
- Annual Bonus Target 20%
- Relocation Assistance
Company overview
The Pfizer Statistics Program represents the statistical and data sciences functions within Pfizer Inc., one of the world's premier biopharmaceutical companies. This specialized program encompasses both the statistical analysis capabilities that support Pfizer's drug development pipeline and the educational initiatives like the Breakthrough Fellowship Program that includes MS Statistics components. As part of Pfizer's Research & Development organization, the Statistics Program plays a critical role in clinical trial design, data analysis, regulatory submissions, and evidence generation for Pfizer's innovative medicines and vaccines. The program employs advanced statistical methodologies and data science techniques to ensure the scientific rigor and integrity of Pfizer's clinical research across therapeutic areas including oncology, internal medicine, immunology, and vaccines. Through its integration with Pfizer's global operations, the Statistics Program contributes to the company's mission of delivering breakthroughs that change patients' lives by providing robust statistical support from early discovery through post-marketing surveillance.